2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Ian McGowan: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally Rectal formulation (RF) of tenofovir 1% gel, Vaginal formulations (original VF and reduced vaginal glycerin formulation RGVF) of tenofovir 1% gel, Universal HEC Placebo Gel Formulation - HIV Prevention | Phase 1 | Completed | Ian McGowan | 13 | 2013-03-01 | 2013-11-07 |
| An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations Rectal formulation (RF) of tenofovir 1% gel, Vaginal formulation (VF) of tenofovir 1% gel, Reduced glycerin vaginal formulation (RGVF) of tenofovir 1% gel - HIV Prevention | Phase 1 | Completed | Ian McGowan | 9 | 2013-03-01 | 2014-05-08 |
Gels (2) · Tenofovir (2) · Seeds (1)
United States (2)
U19AI082637 (2)